Immunization

In an open letter, Pfizer Chairman and CEO wrote that safety and efficacy data for its COVID-19 vaccine candidate may be ready by the third week of November for FDA submission.

The BCG vaccine decreased the overall risk of new respiratory infections in elderly adults, according to the study results.

A new report from the National Academies of Sciences, Engineering, and Medicine include pharmacists in the priority group for receiving the COVID-19 vaccine when available.

Amid this unprecedented flu season, experts recommend co-administering flu and shingles vaccines.

Moderna’s COVID-19 mRNA vaccine candidate appears to induce as strong an immune response in older adults as in younger adults, according to an interim analysis.

The report contains new recommendations for the administration of booster doses of serogroup B meningococcal vaccine for those at increased risk of the disease.

Approximately 1-third of parents who participated in a national survey said they are unlikely to have their child vaccinated against the flu amid the pandemic.

Anticipating higher demand for the flu vaccine this season, many pharmacy chains are expanding their services.

A recent report looked at whether human papilloma virus (HPV) vaccination coverage will meet the Healthy People 2020 goal.

Johnson & Johnson has launched its large-scale phase 3 trial for Janssen’s COVID-19 vaccine candidate.

The Trump administration released its COVID-19 vaccine strategy, with pharmacies among the list of suggested providers for distribution.

Survey responses indicated that almost 7 in 10 Americans are willing to get a COVID-19 vaccine when it becomes available.

After a temporary pause, investigators have received the green light to resume clinical trials for COVID-19 vaccine candidate AZD1222 following a safety review.

Albertsons announced its pharmacies will begin to offer vaccinations to children 3 years and older nationwide.

State-licensed pharmacists and pharmacy interns will be able to order and administer coronavirus disease 2019 vaccines under certain conditions.

NACDS is launching a nationwide awareness campaign on the importance of getting the flu vaccine this fall.

AstraZeneca’s investigational coronavirus disease 2019 (COVID-19) vaccine candidate, AZD1222, has expanded into a phase 3 clinical trial.

New data show that the percentage of adults over the age of 60 years old who received the shingles vaccine has jumped from 6.7% in 2008 to 34.5% in 2018.

A survey conducted by NCPA polled nearly 800 community pharmacy owners/managers on whether they plan to offer a COVID-19 vaccine in their pharmacies.

Results of a new study on immunization rates and current barriers at Wisconsin pharmacies demonstrated that collaborating with physicians could provide significant benefits to patients.

NACDS is urging states to provide clarity on pharmacist-provided childhood vaccinations, and enhance overall patient access to vaccines.

ASHP issued its recommended principles for the development, distribution, allocation, and oversight of an eventual COVID-19 vaccine.

Experts caution about safety measures to take when offering parking lot vaccines.

Primary updates to the guidance includes the composition of the 2020-2021 flu vaccines and the recent licensures of 2 new influenza vaccines.

A school flu vaccine program resulted in decreased influenza hospitalizations for all age groups and fewer illness-related school absences, suggesting herd immunity.